Top

Efficacy and Toxicity of ponatinib and 2nd generation TKI given after allogeneic SCT in Ph+ adult ALL.

Study number:

84210101

Short title:

TKI 2nd/mrd generation in Ph+ ALL

Study status:

Ongoing Data Collection

Deadline for data collection:

Study design:

Primary objective:

Key inclusion criteria:

Country:

Principal investigator:

Klaus HIRSCHBUEHL

Principal investigator email:

EBMT Study coordinator:

Mohamed HOUHOU

Study coordinator email:

mohamed.houhou@upmc.fr